Global Health Data Exchange - Discover the World's Health Data

A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint

Nav

General Info
Geography 
Austria (AUT)
Wien
Coverage type 
Subnational
Time period covered 
01/2020 - 12/2020